Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

An outpatient program to treat deep venous thrombosis with low-molecular-weight heparin.

Pearson SD, Blair R, Halpert A, Eddy E, Mckean S.

Eff Clin Pract. 1999 Sep-Oct;2(5):210-7.

PMID:
10623053
3.
4.

Assessment of outpatient treatment of deep-vein thrombosis with low-molecular-weight heparin.

Harrison L, McGinnis J, Crowther M, Ginsberg J, Hirsh J.

Arch Intern Med. 1998 Oct 12;158(18):2001-3.

PMID:
9778199
5.

Outpatient treatment of venous thromboembolism with low-molecular-weight heparin: an economic evaluation.

Huse DM, Cummins G, Taylor DC, Russell MW.

Am J Manag Care. 2002 Jan;8(1 Suppl):S10-6.

6.

Outpatient management of DVT using low molecular weight heparin and a hospital outreach service.

Rymes NL, Lester W, Connor C, Chakrabarti S, Fegan CD.

Clin Lab Haematol. 2002 Jun;24(3):165-70.

PMID:
12067281
7.

Low-molecular-weight heparin in outpatient treatment of DVT.

Yeager BF, Matheny SC.

Am Fam Physician. 1999 Feb 15;59(4):945-52. Review.

8.

Shifting from inpatient to outpatient treatment of deep vein thrombosis in a tertiary care center: a cost-minimization analysis.

Boucher M, Rodger M, Johnson JA, Tierney M.

Pharmacotherapy. 2003 Mar;23(3):301-9.

PMID:
12627927
9.
10.

The outpatient treatment of deep vein thrombosis delivers cost savings to patients and their families, compared to inpatient therapy.

Rodger MA, Gagné-Rodger C, Howley HE, Carrier M, Coyle D, Wells PS.

Thromb Res. 2003;112(1-2):13-8.

PMID:
15013267
11.

Cost savings and effectiveness of outpatient treatment with low molecular weight heparin of deep vein thrombosis in a community hospital.

Lee M, Pao D, Hsu T, Sonderskov A.

Can J Clin Pharmacol. 2004 Spring;11(1):e17-27. Epub 2004 Apr 1.

PMID:
15226523
12.

Outpatient treatment of deep venous thrombosis in diverse inner-city patients.

Dunn AS, Schechter C, Gotlin A, Vomvolakis D, Jacobs E, Sacks HS, Coller B.

Am J Med. 2001 Apr 15;110(6):458-62.

PMID:
11331057
13.
14.

Outpatient therapy with low molecular weight heparin for the treatment of venous thromboembolism: a review of efficacy, safety, and costs.

Segal JB, Bolger DT, Jenckes MW, Krishnan JA, Streiff MB, Eng J, Tamariz LJ, Bass EB.

Am J Med. 2003 Sep;115(4):298-308. Review.

PMID:
12967695
15.

Economic evaluation of outpatient treatment with low-molecular-weight heparin for proximal vein thrombosis.

O'Brien B, Levine M, Willan A, Goeree R, Haley S, Blackhouse G, Gent M.

Arch Intern Med. 1999 Oct 25;159(19):2298-304.

PMID:
10547169
16.
17.
18.

Outpatient management of deep vein thrombosis.

O'Shaughnessy DF, Tovey C, Miller AL, O'Neill V, Rana PS, Akbar S, Thomas MH.

J Accid Emerg Med. 1998 Sep;15(5):292-3.

19.

Treatment of deep vein thrombosis using low-molecular-weight heparins.

Groce JB 3rd.

Am J Manag Care. 2001 Nov;7(17 Suppl):S510-5; discussion S515-23. Review.

20.

Replacing inpatient care by outpatient care in the treatment of deep venous thrombosis--an economic evaluation. TASMAN Study Group.

van den Belt AG, Bossuyt PM, Prins MH, Gallus AS, Büller HR.

Thromb Haemost. 1998 Feb;79(2):259-63.

PMID:
9493572

Supplemental Content

Support Center